In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Antimalarial drugs play an important role in the control and treatment of malaria, a deadly disease caused by the protozoan parasite Plasmodium spp. The development of novel antimalarial agents effective against drug-resistant malarial parasites is urgently needed. The novel derivatives, SKM13-MeO and SKM13-F, were designed based on an SKM13 template by replacing the phenyl group with electron-donating (-OMe) or electron-withdrawing groups (-F), respectively, to reverse the electron density. A colorimetric assay was used to quantify cytotoxicity, and in vitro inhibition assays were performed on 3 different blood stages (ring, trophozoite, and schizonts) of P. falciparum 3D7 and the ring/mixed stage of D6 strain after synchronization. The in vitro cytotoxicity analysis showed that 2 new SKM13 derivatives reduced the cytotoxicity of the SKM13 template. SKM13 maintained the IC50 at the ring and trophozoite stages but not at the schizont stage. The IC50 values for both the trophozoite stage of P. falciparum 3D7 and ring/mixed stages of D6 demonstrated that 2 SKM13 derivatives had decreased antimalarial efficacy, particularly for the SKM13-F derivative. SKM13 may be comparably effective in ring and trophozoite, and electron-donating groups (-OMe) may be better maintain the antimalarial activity than electron-withdrawing groups (-F) in SKM13 modification.
Abstract
Antimalarial drugs play an important role in the control and treatment of malaria, a deadly disease caused by the protozoan parasite Plasmodium spp. The development of novel antimalarial agents effective against drug-resistant malarial parasites is urgently needed. The novel derivatives, SKM13-MeO and SKM13-F, were designed based on an SKM13 template by replacing the phenyl group with electron-donating (-OMe) or electron-withdrawing groups (-F), respectively, to reverse the electron density. A colorimetric assay was used to quantify cytotoxicity, and in vitro inhibition assays were performed on 3 different blood stages (ring, trophozoite, and schizonts) of P. falciparum 3D7 and the ring/mixed stage of D6 strain after synchronization. The in vitro cytotoxicity analysis showed that 2 new SKM13 derivatives reduced the cytotoxicity of the SKM13 template. SKM13 maintained the IC50 at the ring and trophozoite stages but not at the schizont stage. The IC50 values for both the trophozoite stage of P. falciparum 3D7 and ring/mixed stages of D6 demonstrated that 2 SKM13 derivatives had decreased antimalarial efficacy, particularly for the SKM13-F derivative. SKM13 may be comparably effective in ring and trophozoite, and electron-donating groups (-OMe) may be better maintain the antimalarial activity than electron-withdrawing groups (-F) in SKM13 modification.
참고문헌 (13)
- "Malaria"[URL]
- Tafere Mulaw Belete, "<p>Recent Progress in the Development of New Antimalarial Drugs with Novel Targets<", p>, 2020, pp.14, 3875~3889[DOI]
- Danny W. Wilson, "Defining the Timing of Action of Antimalarial Drugs against Plasmodium falciparum", Antimicrobial Agents and Chemotherapy, 57(3), pp.1455~1467 (2013), American Society for Microbiology[DOI]
- Didier Menard, "Antimalarial Drug Resistance: A Threat to Malaria Elimination", Cold Spring Harbor Perspectives in Medicine, 7(7), pp.a025619~ (2017), Cold Spring Harbor Laboratory[DOI]
- Seon-Ju Yeo, "Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria", Malaria Journal, 16(1), pp.80~ (2017), Springer Science and Business Media LLC[DOI]
- Kieran Tebben, "Determination of the stage composition of Plasmodium infections from bulk gene expression data", mSystems, 7(4), pp.e0025822~ (2022), American Society for Microbiology[DOI]
- Tosin Opadokun, "Protein Profiling of Malaria-Derived Extracellular Vesicles Reveals Distinct Subtypes", Membranes, 12(4), pp.397~ (2022), MDPI AG[DOI]
- Renee N Roberts, "Expression profile of the Plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700", Malaria Journal, 12(1), pp.66~ (2013), Springer Science and Business Media LLC[DOI]
- Daria Van Tyne, "Plasmodium falciparumgene expression measured directly from tissue during human infection", Genome Medicine, 6(11), pp.110~ (2014), Springer Science and Business Media LLC[DOI]
- Htut ZW, "Artemisinin resistance in Plasmodium falciparum malaria", N Engl J Med, 361, pp.1807~1808 (2009)
- Bernardo J Foth, "Quantitative protein expression profiling reveals extensive post-transcriptional regulation and post-translational modifications in schizont-stage malaria parasites", Genome Biology, 9(12), pp.R177~ (2008), Springer Science and Business Media LLC[DOI]
- Yuanting Cai, "Electrophilic aromatic substitution reactions of compounds with Craig-Möbius aromaticity", Proceedings of the National Academy of Sciences, 118(39), pp.e210231011~ (2021), Proceedings of the National Academy of Sciences[DOI]
- Harvie P Portugaliza, "Artemisinin exposure at the ring or trophozoite stage impacts Plasmodium falciparum sexual conversion differently", eLife, 9, pp.e60058~ (2020), eLife Sciences Publications, Ltd[DOI]